RecruitingNCT07538622

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

Sponsor

Zenflow, Inc.

Enrollment

300 participants

Start Date

Jul 29, 2026

Study Type

OBSERVATIONAL

Conditions

BPH (Benign Prostatic Hyperplasia)

Summary

The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Zenflow Spring System for people with bph (benign prostatic hyperplasia). The study is currently recruiting participants at 8 locations. People eligible for this study include men aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEZenflow Spring System

Minimally Invasive Treatment for LUTS associated with BPH

Locations(8)

Chopra Urology

Phoenix, Arizona, United States

San Diego Clinical Trials

La Mesa, California, United States

Gulf Coast Clinical Trial Associates / Florida Urology Partners

Tampa, Florida, United States

Avant Concierge Urology

Winter Garden, Florida, United States

Dr Slade Urology

Boise, Idaho, United States

The Smith Institute of Urology/Northwell Health

Syosset, New York, United States

START Research

Myrtle Beach, South Carolina, United States

Midtown Urology Associates

Austin, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07538622

Related Trials

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

NCT07789041

Transurethral Thermodilatation vs. Prostatic Urethral Lift for Moderate-to-Severe BPH

NCT07759752

Sonablate HIFU International Registry for PC & BPH Patients

NCT07757490

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT07741656

A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia

NCT075837061 location